Public Sector Pension Investment Board Gilead Sciences, Inc. Transaction History

Public Sector Pension Investment Board

$15.9 Billion
Q2 2024

A detailed history of Public Sector Pension Investment Board transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 47,722 shares of GILD stock, worth $4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,722

Previous 27,602 72.89%

Holding current value

$4 Million

Previous $2.02 Million 62.0%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1.27 Million - $1.47 Million	20,120 Added 72.89%	47,722 $3.27 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $57,264 - $69,832	-800 Reduced 2.82%	27,602 $2.02 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $7.7 Million - $8.73 Million	-105,068 Reduced 78.72%	28,402 $2.3 Million
Q3 2023 Nov 22, 2023	BUY	$73.94 - $80.67 $1.04 Million - $1.13 Million	14,029 Added 11.75%	133,470 $10 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $1.35 Million - $1.54 Million	-17,755 Reduced 12.94%	119,441 $9.21 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $1.47 Million - $1.67 Million	-18,956 Reduced 12.14%	137,196 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $29.8 Million - $42.8 Million	-477,868 Reduced 75.37%	156,152 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $30.6 Million - $34.9 Million	513,370 Added 425.5%	634,020 $39.1 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $3.19 Million - $3.6 Million	-55,352 Reduced 31.45%	120,650 $7.46 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $29 Million - $36.3 Million	-500,310 Reduced 73.98%	176,002 $10.5 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $17.3 Million - $19.7 Million	-267,160 Reduced 28.32%	676,312 $49.1 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $30.2 Million - $32.6 Million	446,870 Added 89.99%	943,472 $65.9 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $18.9 Million - $20.7 Million	297,850 Added 149.86%	496,602 $34.2 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $850,920 - $970,899	14,182 Added 7.68%	198,752 $12.8 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.68 Million - $3.05 Million	-47,302 Reduced 20.4%	184,570 $10.8 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $6.89 Million - $8.66 Million	110,900 Added 91.67%	231,872 $14.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $397,870 - $462,000	-5,500 Reduced 4.35%	120,972 $9.31 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $23.5 Million - $30 Million	-374,590 Reduced 74.76%	126,472 $9.46 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $152,571 - $167,823	-2,476 Reduced 0.49%	501,062 $32.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $13 Million - $14.4 Million	208,283 Added 70.54%	503,538 $31.9 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $3.68 Million - $4.13 Million	59,500 Added 25.24%	295,255 $19.9 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $1.38 Million - $1.54 Million	21,996 Added 10.29%	235,755 $15.3 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $357,186 - $466,100	5,900 Added 2.84%	213,759 $13.4 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $7.99 Million - $8.85 Million	-112,100 Reduced 35.04%	207,859 $16 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $16 Million - $18.7 Million	247,000 Added 338.55%	319,959 $22.7 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $203,952 - $248,640	2,800 Added 3.99%	72,959 $5.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5.06 Million - $6 Million	70,159	70,159 $0

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Gilead Sciences, Inc. Transaction History